Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
复制标题
DOI:
10.1126/science.aan4665
复制
发表时间:
2018-04-27
期刊:
影响因子:
--
通讯作者:
Snyder SH
中科院分区:
文献类型:
--
作者:
Kornberg MD;Bhargava P;Kim PM;Putluri V;Snowman AM;Putluri N;Calabresi PA;Snyder SH
Activated immune cells undergo a metabolic switch to aerobic glycolysis akin to the Warburg effect, presenting a potential therapeutic target in autoimmune disease. Dimethyl fumarate, a derivative of the Krebs cycle intermediate fumarate, is an immunomodulatory drug used to treat multiple sclerosis and psoriasis. Although its therapeutic mechanism remains uncertain, it covalently modifies cysteine residues in a process termed “succination.” Here, we show that dimethyl fumarate succinates and inactivates the catalytic cysteine of the glycolytic enzyme GAPDH both in vitro and in vivo. It thereby downregulates aerobic glycolysis in activated myeloid and lymphoid cells, which mediates its anti-inflammatory effects. Our findings provide mechanistic insight into immune modulation by dimethyl fumarate and represent a proof of concept that aerobic glycolysis is a therapeutic target in autoimmunity.
登录
查看更多内容
影响因子:
44.1
作者:
通讯作者:
--
影响因子:
64.5
作者:
Chang CH;Curtis JD;Maggi LB Jr;Faubert B;Villarino AV;O'Sullivan D;Huang SC;van der Windt GJ;Blagih J;Qiu J;Weber JD;Pearce EJ;Jones RG;Pearce EL
通讯作者:
Pearce EL
影响因子:
29
作者:
Macintyre AN;Gerriets VA;Nichols AG;Michalek RD;Rudolph MC;Deoliveira D;Anderson SM;Abel ED;Chen BJ;Hale LP;Rathmell JC
通讯作者:
Rathmell JC
影响因子:
7.7
作者:
Blatnik, Matthew;Frizzell, Norma;Baynes, John W.
通讯作者:
Baynes, John W.
DOI:
10.1016/0167-4838(91)90058-8
发表时间:
1991-04-08
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA
影响因子:
--
作者:
SAKAI, K;HASUMI, K;ENDO, A
通讯作者:
ENDO, A